Anil Malhotra, M.D.

Anil Malhotra, M.D.


Director of Psychiatry Research
Zucker Hillside Hospital
Professor, Department of Molecular Medicine and
Department of Psychiatry
Hofstra North Shore-LIJ School of Medicine
Investigator, Feinstein Institute for Medical Research

Dr. Malhotra’s research group focuses on identifying the biological underpinnings of schizophrenia and the mechanism of action of antipsychotic drugs. His group has identified several genes associated with increased risk for developing the disorder, determined their relationship to important clinical manifestations of illness, including cognitive impairment, and examined the role of genetic factors in predicting individual responses to pharmacological treatment. His group published the first genome-wide association study of schizophrenia and developed a new analytic strategy to assess these data. A recent project provides new evidence for the role of specific genetic factors in vulnerability to antipsychotic drug-induced weight gain, a common side effect of treatment.

Following his research fellowship at the NIMH, Dr. Malhotra moved to the Zucker-Hillside Hospital, where he developed an internationally recognized molecular genetics program focused on the major neuropsychiatric disorders.

NARSAD Grants: Young Investigator 1999, Independent Investigator 2001 and 2006